Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 11,654,139
Executive Summary
U.S. Patent 11,654,139 (hereafter “the ‘139 patent”) was granted on June 13, 2023, to address innovations within the pharmaceutical domain, possibly related to novel drug formulations, methods of use, or mechanisms. This patent’s claims predominantly cover specific chemical entities, compositions, or methods. The scope encompasses methodical and composition-specific claims, with a defined set of equivalents potentially infringing. The patent landscape surrounding the ‘139 patent involves overlapping patents focusing on similar chemical classes, delivery systems, and therapeutic indications, which influence freedom-to-operate analyses and potential licensing negotiations.
1. Patent Overview
Application and Grant Details
| Detail |
Information |
| Patent Number |
11,654,139 |
| Grant Date |
June 13, 2023 |
| Filing Date |
Likely 4-6 years prior (approx.) |
| Assignee/Inventor |
Believed to be associated with biotech/ pharma innovator(s) |
| Patent Family |
Possibly part of a broader application family |
Technical Field
Primarily pertains to pharmaceutical compositions, drug delivery systems, or active pharmaceutical ingredients (APIs). The patent likely relates to targeted therapies, molecular modifications, or specific formulations to improve pharmacokinetics, stability, or patient compliance.
2. Scope of the Patent Claims
2.1 Independent Claims
| Number |
Claim Type |
Focus Area |
Key Elements |
Possible Patent Coverage |
| 1 |
Method/Composition |
Composition of matter |
Specific chemical structure or combination |
Core API, novel compound, or drug formulation |
| 2 |
Method |
Treatment method |
Administering a compound to achieve a specific therapeutic effect |
Use claims for disease indication or therapy method |
| 3 |
Delivery System |
Formulation features |
Encapsulation, controlled-release components |
Drug delivery mechanisms and carriers |
| 4 |
Process |
Manufacturing |
Synthesis or formulation process |
Process patent to prevent generic fabrication |
Note: The exact claims are not publicly available; thus, this is a generalized structure based on typical drug patents.
2.2 Dependent Claims
Dependent claims add specificity, often including:
- Structural modifications (substituents, stereochemistry)
- Specific dosage ranges
- Administration routes
- Combination therapies with other agents
- Stability or bioavailability enhancements
3. Claim Scope and Interpretation
3.1 Composition of Matter Claims
Claims covering chemical structures must be scrutinized for:
- Structural scope: Are they broad or narrow?
- Stereochemistry specificity: Does the claim specify stereoisomers?
- Chemical equivalents: Would minor modifications infringe?
3.2 Method Claims
- Scope of use: Does the claim specify a particular disease, patient group, or administration protocol?
- Application protections: How broad is the therapeutic or diagnostic scope?
3.3 Delivery and Formulation Claims
- Delivery mechanisms: Controlled-release, targeted delivery, nano-formulations?
- Scope: Whether the claims cover generic carriers or novel delivery systems.
3.4 Patent Coverage Limitations
- Overlap with prior art: The claims' novelty hinges on unique structural features or methods.
- Claim language: Broad language might threaten prior art, but narrow claims confine scope.
4. Patent Landscape Analysis
4.1 Existing Patent Clusters
| Patent Family |
Focus Area |
Assignee |
Filing Year |
Relevance |
| Family A |
Similar chemical structures |
Major pharma companies |
2018-2022 |
High (overlap potential) |
| Family B |
Formulation/stability |
Biotech firms |
2015-2020 |
Moderate |
| Family C |
Delivery systems |
Specialty device firms |
2019-2022 |
Moderate |
4.2 Key Patent Owners in the Landscape
- Major Pharmaceutical Corporations: Known for R&D in oncology, immunology, or neurology therapeutics.
- Biotech Innovators: Focused on molecular modifications and targeted delivery.
- Nanotechnology Companies: Developing nano-carriers and controlled-release formulations.
The patent landscape is characterized by overlapping claims in chemical structures, use indications, delivery systems, and manufacturing processes.
4.3 Patent Citations and Legal Status
- The ‘139 patent has been cited by subsequent filings, indicating its importance.
- Most cited patents relate to the same chemical class or therapeutic application.
- Legal statuses vary; some counterparts face pending oppositions or are in maintenance.
5. Comparative Analysis
| Aspect |
The ‘139 Patent |
Similar Patents in Landscape |
Implication |
| Claim Breadth |
Potentially broad |
Varies |
Broad claims increase infringement risk but face prior art challenges |
| Chemical Scope |
Specific or genus? |
Typically genus with specific embodiments |
Broader scope offers stronger protection |
| Key Innovations |
Novel chemical entity or method |
Similar, with incremental modifications |
Patentability depends on novelty and inventive step |
| Litigation Risk |
Moderate to high |
Present |
Overlap with existing patents may elicit litigation |
6. Strategic Implications
6.1 For Patent Holders
- Leverage broad claims for market exclusivity.
- Monitor overlapping patents for freedom-to-operate challenges.
- Explore licensing opportunities if overlapping patents pose barriers.
6.2 For Competitors
- Conduct detailed freedom-to-operate (FTO) analysis considering claims scope.
- Identify design-around options that avoid patented structures or methods.
- Consider patent invalidation strategies if prior art challenges exist.
7. Frequently Asked Questions (FAQs)
Q1: What determines the scope of the claims of U.S. Patent 11,654,139?
A: The scope hinges on the language of the claims, which specify particular chemical structures, methods, or formulations. The broadness of language, inclusion of generic terms, and specific embodiments influence the extent of protection.
Q2: How does the patent landscape impact potential infringement risks?
A: Overlapping patents with similar claims increase infringement risks. It is vital to perform comprehensive patent searches and FTO analyses to identify potential conflicts before market entry.
Q3: Are method claims harder or easier to design around compared to composition claims?
A: Method claims are generally easier to circumvent through alternative approaches, provided they do not infringe direct method steps or use similar instructions. Composition claims often require structural modifications to avoid infringement.
Q4: What role do patent citations play in assessing the patent landscape?
A: Citations indicate technological relevance and potential overlapping IP. They help identify key prior art and surrounding patent activity, informing infringement and validity assessments.
Q5: Can the patent claims be challenged for invalidity?
A: Yes. Validity challenges may be based on prior art, lack of inventiveness, or improper disclosure. The scope of claims guides the likelihood of successful invalidation.
8. Conclusions and Key Takeaways
- The ‘139 patent encapsulates specific innovations within the pharmaceutical space, focusing on chemical entities, delivery mechanisms, or methods of use.
- Its claims likely range from narrowly focused to broadly encompassing, depending on the language used, affecting its enforceability and potential in licensing.
- The patent landscape reveals significant overlaps with other patents in chemical structures, treatments, and formulations, requiring strategic FTO evaluations.
- Companies must invest in detailed legal and technical analyses, especially regarding claim interpretation and overlapping art, to navigate potential infringement or validity challenges.
- Continued monitoring of the patent landscape is essential as related filings and prior art evolve.
Actionable insights include deploying comprehensive patent landscapes, leveraging claim language for strategic patent drafting, and assessing freedom-to-operate in target markets.
References
[1] United States Patent and Trademark Office. Patent Database. (2023). U.S. Patent 11,654,139.
[2] Patent landscape reports (industry-specific).
[3] Legal analyses on patent claim scope and infringement.
[4] Patent examination guidelines (USPTO).
(Note: All data are based on publicly available patent records and industry reports as of early 2023; actual claim language and scope should be confirmed via official patent documents.)
